Article Versions Notes

Yu F-Y, Xu Q, Zhao X-Y, Mo H-Y, Zhong Q-H, Luo L, Lau ATY, Xu Y-M. The Atypical MAP Kinase MAPK15 Is Required for Lung Adenocarcinoma Metastasis via Its Interaction with NF-κB p50 Subunit and Transcriptional Regulation of Prostaglandin E2 Receptor EP3 Subtype. Cancers. 2023; 15(5):1398. https://doi.org/10.3390/cancers15051398

Yu, Fei-Yuan, Qian Xu, Xiao-Yun Zhao, Hai-Ying Mo, Qiu-Hua Zhong, Li Luo, Andy T. Y. Lau, and Yan-Ming Xu. 2023. "The Atypical MAP Kinase MAPK15 Is Required for Lung Adenocarcinoma Metastasis via Its Interaction with NF-κB p50 Subunit and Transcriptional Regulation of Prostaglandin E2 Receptor EP3 Subtype" Cancers 15, no. 5: 1398. https://doi.org/10.3390/cancers15051398

Yu, F. -Y., Xu, Q., Zhao, X. -Y., Mo, H. -Y., Zhong, Q. -H., Luo, L., Lau, A. T. Y., & Xu, Y. -M. (2023). The Atypical MAP Kinase MAPK15 Is Required for Lung Adenocarcinoma Metastasis via Its Interaction with NF-κB p50 Subunit and Transcriptional Regulation of Prostaglandin E2 Receptor EP3 Subtype. Cancers, 15(5), 1398. https://doi.org/10.3390/cancers15051398